Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

2.
3.

A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes.

Sun J, Bird CH, Sutton V, McDonald L, Coughlin PB, De Jong TA, Trapani JA, Bird PI.

J Biol Chem. 1996 Nov 1;271(44):27802-9.

4.

Differential expression of proteinase inhibitor-9 and granzyme B mRNAs in activated immunocompetent cells.

Horie O, Saigo K, Murayama T, Ryo R.

Tohoku J Exp Med. 2005 Feb;205(2):103-13.

5.

The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses.

Buzza MS, Hirst CE, Bird CH, Hosking P, McKendrick J, Bird PI.

Cell Immunol. 2001 May 25;210(1):21-9.

PMID:
11485349
6.
7.

Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6.

Barrie MB, Stout HW, Abougergi MS, Miller BC, Thiele DL.

J Immunol. 2004 May 15;172(10):6453-9.

8.
10.

Proteinase inhibitor-9 expression is induced by maturation in dendritic cells via p38 MAP kinase.

Bots M, de Bruin E, Rademaker-Koot MT, Medema JP.

Hum Immunol. 2007 Dec;68(12):959-64. doi: 10.1016/j.humimm.2007.10.011. Epub 2007 Nov 20.

PMID:
18191723
11.

alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro.

Nita IM, Serapinas D, Janciauskiene SM.

Int J Biochem Cell Biol. 2007;39(6):1165-76. Epub 2007 Mar 1.

PMID:
17448722
12.

Influence of pentoxifylline on natural cytotoxicity and expression of granzymes and PI-9, a specific granzyme B inhibitor.

Lazarczyk M, Dziunycz P, Niderla J, Milewski L, Lazarczyk MA, Boszczyk A, Samaha R, Grzela T.

Int J Mol Med. 2006 Jan;17(1):135-9.

PMID:
16328022
13.

The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells.

Bladergroen BA, Strik MC, Wolbink AM, Wouters D, Broekhuizen R, Kummer JA, Hack CE.

Eur J Immunol. 2005 Apr;35(4):1175-83.

14.

The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites.

Bladergroen BA, Strik MC, Bovenschen N, van Berkum O, Scheffer GL, Meijer CJ, Hack CE, Kummer JA.

J Immunol. 2001 Mar 1;166(5):3218-25.

15.

Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo.

Andrew KA, Simkins HM, Witzel S, Perret R, Hudson J, Hermans IF, Ritchie DS, Yang J, Ronchese F.

J Immunol. 2008 Dec 15;181(12):8356-62.

16.
17.

Apoptotic death concurrent with CD3 stimulation in primary human CD8+ T lymphocytes: a role for endogenous granzyme B.

Laforge M, Bidère N, Carmona S, Devocelle A, Charpentier B, Senik A.

J Immunol. 2006 Apr 1;176(7):3966-77.

18.

EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease.

Glaser R, Litsky ML, Padgett DA, Baiocchi RA, Yang EV, Chen M, Yeh PE, Green-Church KB, Caligiuri MA, Williams MV.

Virology. 2006 Mar 1;346(1):205-18.

19.
20.

Immune activation suppresses initiation of lytic Epstein-Barr virus infection.

Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.

Cell Microbiol. 2007 Aug;9(8):2055-69. Epub 2007 Apr 5.

PMID:
17419714

Supplemental Content

Support Center